ZHENYU XU sells shares under 10b5-1 plan (SOPH)
Rhea-AI Filing Summary
ZHENYU XU reported 10b5-1 sales of Common Stock under multiple transactions. The filing lists periodic 10b5-1 dispositions on 01/05/2026, 01/06/2026, 01/13/2026, 01/20/2026, 02/13/2026, 02/19/2026, and 03/13/2026, with reported share amounts of 2006, 3000, 4000, 608, 4000, 608, and 4000 respectively and per-trade proceeds shown in the filing.
The filing also lists 608 Restricted Stock Units to be sold by the issuer on 03/18/2026. Transactions were processed through Morgan Stanley Smith Barney LLC.
Positive
- None.
Negative
- None.
Insights
Structured sales under a 10b5-1 plan and an issuer-designated RSU sale are reported.
The filing documents multiple 10b5-1 sales by ZHENYU XU across seven dates in Jan–Mar 2026, listing per-transaction share counts: 2006, 3000, 4000, 608, 4000, 608, 4000. The excerpt shows per-trade cash amounts tied to each sale.
The excerpt also shows an issuer sale of 608 Restricted Stock Units on 03/18/2026 processed via Morgan Stanley Smith Barney LLC. Cash-flow treatment is the proceeds to the seller; further filing details would clarify net proceeds and any tax-withholding.
Forms indicate routine, pre-arranged dispositions rather than event-driven market activity.
The entries are labeled as 10b5-1 Sales, which the excerpt identifies by date and share count; such labeling typically denotes pre-planned trading instructions. The filing names the executing broker and records gross proceeds per trade.
Regulatory implications are routine disclosure; further filings may show aggregate totals or confirm whether these trades exhausted a plan, but timing and plan terms are not provided in the excerpt.
FAQ
What trades did ZHENYU XU report in the Form 144 for SOPH?
Who executed the reported sales in this Form 144 for SOPH?
Does the filing show any issuer securities being sold for SOPH?
Are the sales described as 10b5-1 in the Form 144 significant disclosure events?